Bellemin Jean-Marc has filed 16 insider transactions across 1 company since January 2023.
Most recent transaction: a option exercise of 8789 shares of IOVANCE BIOTHERAPEUTICS, INC. ($IOVA) on June 02, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 2, 2025 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | Bellemin Jean-Marc | Chief Financial Officer | M | Common Stock | 8789 | $0.00 | 64,993.0000 | 322,868 | 15.64% | 2.72% |
| June 2, 2025 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | Bellemin Jean-Marc | Chief Financial Officer | F | Common Stock | 4464 | $1.76 | 60,529.0000 | 322,868 | 6.87% | 1.38% |
| June 2, 2025 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | Bellemin Jean-Marc | Chief Financial Officer | M | Restricted Stock Units | 8789 | $0.00 | 61,528.0000 | 322,868 | 12.50% | 2.72% |
| March 5, 2025 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | Bellemin Jean-Marc | Chief Financial Officer | A | Restricted Stock Units | 93750 | $0.00 | 93,750.0000 | 289,877 | 9999.99% | 32.34% |
| March 3, 2025 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | Bellemin Jean-Marc | Chief Financial Officer | M | Common Stock | 58590 | $0.00 | 87,938.0000 | 289,877 | 199.64% | 20.21% |
| March 3, 2025 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | Bellemin Jean-Marc | Chief Financial Officer | F | Common Stock | 31734 | $4.04 | 56,204.0000 | 289,877 | 36.09% | 10.95% |
| March 3, 2025 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | Bellemin Jean-Marc | Chief Financial Officer | M | Restricted Stock Units | 58590 | $0.00 | 70,317.0000 | 289,877 | 45.45% | 20.21% |
| Sept. 3, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | Bellemin Jean-Marc | Chief Financial Officer | M | Common Stock | 23438 | $0.00 | 41,239.0000 | 284,817 | 131.67% | 8.23% |
| Sept. 3, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | Bellemin Jean-Marc | Chief Financial Officer | F | Common Stock | 11891 | $10.85 | 29,348.0000 | 284,817 | 28.83% | 4.18% |
| Sept. 3, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | Bellemin Jean-Marc | Chief Financial Officer | M | Restricted Stock Units | 23438 | $0.00 | 23,437.0000 | 284,817 | 50.00% | 8.23% |
| March 1, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | Bellemin Jean-Marc | Chief Financial Officer | A | Restricted Stock Units | 105470 | $0.00 | 105,470.0000 | 235,131 | 9999.99% | 44.86% |
| March 1, 2024 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | Bellemin Jean-Marc | Chief Financial Officer | A | Restricted Stock Units | 46875 | $0.00 | 46,875.0000 | 235,131 | 9999.99% | 19.94% |
| March 2, 2023 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | Bellemin Jean-Marc | Chief Financial Officer | A | Stock Option (right to buy) | 168750 | $0.00 | 168,750.0000 | 159,259 | 9999.99% | 100.00% |
| Jan. 3, 2023 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | Bellemin Jean-Marc | Chief Financial Officer | M | Common Stock | 18850 | $0.00 | 28,354.0000 | 159,259 | 198.34% | 11.84% |
| Jan. 3, 2023 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | Bellemin Jean-Marc | Chief Financial Officer | F | Common Stock | 10553 | $6.11 | 17,801.0000 | 159,259 | 37.22% | 6.63% |
| Jan. 3, 2023 | IOVANCE BIOTHERAPEUTICS, INC. | $IOVA | Bellemin Jean-Marc | Chief Financial Officer | M | Restricted Stock Units | 18850 | $0.00 | 0.0000 | 159,259 | 100.00% | 11.84% |